News

Cynthia Steel, PhD, Joins Glaucoma Research Foundation as CSO

Cynthia Steel, PhD, Joins Glaucoma Research Foundation as CSO

Cynthia Steel Appointed Chief Scientific Officer at GRF

With an impressive two-decade career leading glaucoma research and translational science, Dr. Cynthia Steel is set to enhance the Glaucoma Research Foundation's (GRF) scientific strategy and drive innovation.

Dr. Steel begins her role as Chief Scientific Officer, marking a significant new chapter in her long-standing relationship with GRF, which has lasted over ten years. During this time, she first gained recognition with the Shaffer Grant for Innovative Glaucoma Research, collaborated as an industry partner, and most recently contributed her insights as a member of GRF's Research Committee.

Vision for Innovation and Research

Dr. Steel's appointment comes during a period of expansion for GRF as it seeks to ramp up its research initiatives aimed at curing glaucoma and restoring vision. She will lead scientific programs, shape the research approach, assess program effectiveness, and develop relationships with the global scientific community. Her role also includes simplifying complex research insights to make them accessible to donors, patients, and stakeholders.

Thomas M. Brunner, President and CEO of GRF, expressed enthusiasm about Dr. Steel's arrival, stating, "We are thrilled to welcome Cynthia in this new leadership role as we expand our research investment. Her deep expertise in translational research and drug development will be critical in advancing therapies for patients."

Dr. Steel's Commitment to Advancing Glaucoma Research

In her reflection on joining GRF, Dr. Steel remarked, "I am so excited to join the GRF team after so many years of collaborating. I am confident that my unique bench-to-bedside fluency will help shape GRF's scientific trajectory, and I look forward to guiding its vision with mission-driven leadership." This expectancy reflects the promising future she envisions for the organization and its goals.

The Path of Accomplishment in Glaucoma Research

Dr. Steel has made significant contributions to the field as a specialist in trabecular meshwork cell biology. Her dedication has been towards converting laboratory findings into practical solutions for glaucoma treatment. Dr. Steel received her PhD in Cell Biology, Neurobiology, and Anatomy from Loyola University Chicago, followed by an Executive MBA from the University of South Florida Muma College of Business.

In her previous roles within the private sector, Dr. Steel has excelled in scientific leadership positions at Bausch + Lomb, Qlaris Bio, and Glaukos. Her expertise in research has played a vital part in drug development and commercialization efforts. In addition to her responsibilities at GRF, she will maintain her role as a contracted Science, Engineering, and Technical Advisor for the Advanced Research Projects Agency for Health (ARPA-H).

About Glaucoma Research Foundation

Founded in 1978, the Glaucoma Research Foundation stands as the nation’s oldest and most seasoned institution strictly dedicated to the pursuit of curing glaucoma and enhancing vision through innovative research. For further insights about the organization, visit www.glaucoma.org.

Frequently Asked Questions

Who is Cynthia Steel?

Cynthia Steel, PhD, is an accomplished vision scientist with extensive experience in glaucoma research, now serving as the CSO of Glaucoma Research Foundation.

What does the Chief Scientific Officer do?

The Chief Scientific Officer leads scientific programs, directs research strategy, and enhances relationships with the scientific community, among other responsibilities.

What is the Glaucoma Research Foundation's mission?

The mission of the Glaucoma Research Foundation is to cure glaucoma and restore vision through innovative research efforts.

Where did Dr. Steel receive her education?

Dr. Steel earned her PhD from Loyola University Chicago and completed an Executive MBA at the University of South Florida Muma College of Business.

What experience does Dr. Steel bring to GRF?

Dr. Steel brings two decades of experience in glaucoma research and translational science, having held leadership roles in various organizations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Easterly ROCMuni High Income Fund Lawsuit

Updated Category News Views 156

Overview of the Easterly ROCMuni High Income Fund Lawsuit Investors in the Easterly ROCMuni High Income Municipal Bond Fund are being urged to consider their rights as part of a potential class action lawsuit. This fund was previously known as the Principal Street High Income Municipal Fund and is associated with the James Alpha Funds Trust. Investors who purchased shares...

Continue Reading
BioPhorum Launches Strategic Advisory Board to Foster Collaboration

Updated Category News Views 122

BioPhorum Forms Strategic Advisory Board for Enhanced Collaboration BioPhorum, a trusted name in the pharmaceutical industry, has taken a significant step towards fostering collaboration within the sector. The formation of its inaugural Strategic Advisory Board aims to provide pivotal guidance and insights, driving the overall direction of the organization as it tackles...

Continue Reading
Maxeon Solar and Cypress Creek Partner for Renewable Projects

Updated Category News Views 74

Maxeon Solar Solutions Tapped for Major Solar Projects At a recent clean energy gathering, Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN)—long known for pushing solar technology forward—announced a new collaboration with Cypress Creek Renewables. Together, the companies will deploy Maxeon solar panels across key power plant projects nationwide, expanding reliable...

Continue Reading
Transforming Healthcare: VARON Oxygen Solutions' Global Impact

Updated Category News Views 113

Transforming Healthcare Through Reliable Partnerships In healthcare environments worldwide, a vital force is improving lives—VARON Oxygen Solutions. This company has emerged as a trusted provider of oxygen concentrators, ensuring that patients receive high-quality respiratory care wherever they are, including hospitals and senior living facilities. Bridging Global Gaps...

Continue Reading
Intelligent Blends Elevates Its Game in Functional Beverages

Updated Category News Views 434

Intelligent Blends Enhances Its Market Position New Non-GMO Certification and Enhanced Capabilities Position Company for Expanded Growth in Functional Beverages Intelligent Blends has officially solidified its place as a leader in the "better for you" manufacturing sector, having recently obtained Non-GMO certification. This achievement reflects the company’s commitment...

Continue Reading